If we take four billion eight hundred million, that's in numbers, 4,800,000,000, shares into equation this will never see $0.25.
Based on the facts found on this board, the investors should be rather bearish regarding FITX.
JR can not grant them license. They can only be sent back into to the line to HC, which will take years to review them again since they have much better and trustworthy applicants than Cen Biotech. Even if they are granted license they can not produce a gram of MMJ because they do not have proper facilities for grow-op (only empty poll barns with no infrastructure), nor a proper zoning at their current Lakeshore location.
Taking just those couple of facts into account does not merit enthusiasm to load at these so called low prices. It is still overvalued. Even if it goes to no bid at .0001 it has a greater chance for a reverse split than fulfillment of empty promises given officially by the company and many more speculations thrown into the cyberspace by desperate investors holding a bag.
Market Data 
Markets 
AI
